This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Fujifilm Manufacturing Europe B.v.. Active years: 2012-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tilburg, NL (2012)
- Holland, NL (2013)
Company Filing History:
Years Active: 2012-2013
Title: The Innovations of Sebastianus Gerardus Kluijtmans
Introduction: Sebastianus Gerardus Kluijtmans is a notable inventor hailing from Holland, Netherlands, recognized for his significant contributions to the field of pharmacology. With a total of two patents to his name, Kluijtmans has made strides in developing innovative controlled release compositions, which offer promising advancements in therapeutic treatments.
Latest Patents: Kluijtmans' latest patents focus on controlled release compositions comprising recombinant gelatin. The first patent outlines a method for preparing a controlled release composition, which is a crucial area in pharmacological applications. His second patent also addresses controlled release compositions, specifically those involving cross-linked gelatin and at least one therapeutic protein. This invention emphasizes a specific ratio of the average mesh size of the gelatin matrix to the average hydrodynamic radius of the therapeutic protein, ideally maintaining a ratio smaller than 2, preferably less than 1.5.
Career Highlights: Currently, Kluijtmans is associated with Fujifilm Manufacturing Europe B.V., where he engages in cutting-edge research and development in pharmaceutical innovations. His work at Fujifilm illustrates his commitment to advancing medical technology and improving patient outcomes.
Collaborations: Throughout his career, Kluijtmans has collaborated with esteemed colleagues such as Jan Bastiaan Bouwstra and Marc Sutter. These professional relationships have fostered a creative environment for pioneering new inventions and enhancing existing technologies in the pharmaceutical industry.
Conclusion: Sebastianus Gerardus Kluijtmans exemplifies the spirit of innovation within the realm of pharmacology. His dedication to developing controlled release compositions not only showcases his expertise but also highlights the potential for future advancements in therapeutic applications. As he continues to build upon his research and collaborate with talented individuals, Kluijtmans' contributions are set to leave a lasting impact in the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile